膀胱癌治疗和诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

膀胱癌治疗和诊断市场按产品(治疗和诊断)、癌症类型和地理划分。

市场快照

Bladder Cancer Therapeutics and Diagnostics Market Share
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4 %
Bladder Cancer Therapeutics and Diagnostics Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于对膀胱疾病和可用疗法的认识不断提高,以及医疗保健支出的增加和膀胱癌的负担日益加重,膀胱癌治疗和诊断市场可能会出现快速增长。在过去几年中,全球医疗保健总支出迅速增加。因此,有新的医疗技术、治疗方法和药物可用于治疗膀胱癌疾病,这些疾病主要导致医疗保健成本的整体上升。高昂的药品价格、药品专利到期和医疗保健服务成本占医疗保健支出增长的三分之二。增加服务的支出,包括劳动力和生产力成本(生物制药行业),也是推动医疗保健成本的主要因素之一。

此外,对创新膀胱癌疗法开发的不断研究和管道疗法的可用性正在进一步推动膀胱癌疗法市场的增长。此外,对膀胱癌及其可用疗法的认识的提高以及不断增长的吸烟和烟草消费也在推动市场。

报告范围

根据报告的范围,膀胱癌是一种起源于膀胱细胞的肿瘤。膀胱癌是膀胱内衬有上皮细胞的异常细胞快速、不受控制地生长。这些癌细胞甚至可能通过内膜扩散到膀胱的肌肉壁中。已经开发了几种治疗膀胱癌的疗法,这反过来又对膀胱癌治疗市场产生了很高的需求。

By Product
By Therapeutics
Chemotherapy
Immunotherapy
Other Therapeuticss
By Diagnostics
Cystoscopy
Bladder Ultrasound
Urinalysis
Other Diagnostics
By Cancer Type
Transitional Cell Bladder Cancer
Squamous Cell Bladder Cancer
Other Cancer Types
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计膀胱镜检查将成为预测期内诊断的主要部分

膀胱镜检查是一种使用望远镜观察膀胱和尿道内部的程序。膀胱镜是一种专门的内窥镜,通过尿道插入膀胱,可以直接目视检查尿路上皮。膀胱镜检查具有成本效益。但是,结合其他测试,其成本可能会有所不同。美国每年进行大约 120 万次柔性膀胱镜检查。因此,Cysview 的引入正在推动市场的增长,预计在预测期内将录得更高的增长率。此外,人群中膀胱癌的发病率很高,预计这将在预测期内推动市场。

Bladder Cancer Therapeutics and Diagnostics Market Size

北美市场份额最大

由于该地区不断增加的研发活动和完善的医疗保健基础设施,北美地区占有最大份额。此外,大量生物制品公司和生物制药公司的存在正在促进膀胱癌治疗和诊断市场的大规模和出色的增长。

北美在商业领域引入的新诊断方式的采用率也最高。这一趋势与世界其他地区形成鲜明对比,在这些地区,最广泛采用的癌症诊断技术至少已有十年历史。因此,北美在膀胱治疗和诊断市场的市场规模方面处于领先地位。

Bladder Cancer Therapeutics and Diagnostics Market Growth

竞争格局

活跃在市场上的主要公司是阿斯利康、百时美施贵宝公司、礼来公司、葛兰素史克公司、F. Hoffmann-La Roche Ltd、诺华和辉瑞公司。市场上的公司正专注于产品创新、扩张、寻找新市场或创新其核心竞争力,以扩大其市场份额。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Awareness on Bladder Diseases and Available Therapies

      2. 4.2.2 Increasing Healthcare Expenditure

      3. 4.2.3 Increasing Burden of Bladder Cancer

    3. 4.3 Market Restraints

      1. 4.3.1 Rise in the Number of Patent Expiration and Increased Use of Generic Drugs

      2. 4.3.2 Asymptomatic Nature of the Disease

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. 5.1.1.1 Chemotherapy

        2. 5.1.1.2 Immunotherapy

        3. 5.1.1.3 Other Therapeuticss

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Cystoscopy

        2. 5.1.2.2 Bladder Ultrasound

        3. 5.1.2.3 Urinalysis

        4. 5.1.2.4 Other Diagnostics

    2. 5.2 By Cancer Type

      1. 5.2.1 Transitional Cell Bladder Cancer

      2. 5.2.2 Squamous Cell Bladder Cancer

      3. 5.2.3 Other Cancer Types

    3. 5.3 By Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AstraZeneca PLC

      2. 6.1.2 Bristol-Myers Squibb Company

      3. 6.1.3 Eli Lilly and Company

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 Novartis International AG

      7. 6.1.7 Pfizer Inc.

      8. 6.1.8 Sanofi SA

      9. 6.1.9 Endo Pharmaceuticals Inc.

      10. 6.1.10 Johnson & Johnson (Janssen Pharmaceutical)

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Bladder Cancer Therapeutics and Diagnostics Market market is studied from 2018 - 2026.

The Bladder Cancer Therapeutics and Diagnostics Market is growing at a CAGR of 4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Johnson & Johnson (Janssen Pharmaceutical), F. Hoffmann-La Roche Ltd are the major companies operating in Bladder Cancer Therapeutics and Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!